Evidence map›Paper›PMID 35296519›Full record

SynthesisBMJ (Clinical research ed.)2022

SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis.

John Allotey, Shaunak Chatterjee, Tania Kew, Andrea Gaetano, Elena Stallings, Silvia Fernández-García, Magnus Yap, Jameela Sheikh, Heidi Lawson, Dyuti Coomar and 28 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ (Clinical research ed.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 9 pooled it
29.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 9 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors at 10 institutions in 6 countries.

John AlloteyWHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Shaunak ChatterjeeBirmingham Medical School, University of Birmingham, Birmingham, UK.
Tania KewBirmingham Medical School, University of Birmingham, Birmingham, UK.
Andrea GaetanoClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
Elena StallingsClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
Silvia Fernández-GarcíaClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
Magnus YapBirmingham Medical School, University of Birmingham, Birmingham, UK.
Jameela SheikhBirmingham Medical School, University of Birmingham, Birmingham, UK.
Heidi LawsonBirmingham Medical School, University of Birmingham, Birmingham, UK.
Dyuti CoomarWHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Anushka DixitBirmingham Medical School, University of Birmingham, Birmingham, UK.
Dengyi ZhouBirmingham Medical School, University of Birmingham, Birmingham, UK.
Rishab BalajiBirmingham Medical School, University of Birmingham, Birmingham, UK.
Megan LittmodenBirmingham Medical School, University of Birmingham, Birmingham, UK.
Yasmin KingUniversity of Nottingham, Nottingham, UK.
Luke DebenhamBirmingham Medical School, University of Birmingham, Birmingham, UK.
Anna Clavé LlavallBirmingham Medical School, University of Birmingham, Birmingham, UK.
Kehkashan AnsariWHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Gurimaan SandhuBirmingham Medical School, University of Birmingham, Birmingham, UK.
Adeolu BanjokoBirmingham Medical School, University of Birmingham, Birmingham, UK.
Kate WalkerUniversity of Nottingham, Nottingham, UK.
Keelin O'DonoghueUniversity College Cork, Cork, Ireland.
Madelon van WelyNetherlands Satellite of the Cochrane Gynaecology and Fertility Group, Amsterdam University Medical Centre, Amsterdam, Netherlands.
Elizabeth van LeeuwenDepartment of Obstetrics and Gynaecology, Amsterdam University Medical Centre, Amsterdam, Netherlands.
Elena KostovaNetherlands Satellite of the Cochrane Gynaecology and Fertility Group, Amsterdam University Medical Centre, Amsterdam, Netherlands.
Heinke KunstBlizard Institute, Queen Mary University of London, London, UK.
Asma KhalilSt George's University London, London, UK.
Vanessa BrizuelaUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Nathalie BroutetUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Edna KaraUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Caron Rahn KimUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Anna ThorsonUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Olufemi T OladapoUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Javier ZamoraWHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Mercedes BonetUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Lynne MofensonElizabeth Glaser Paediatric AIDS Foundation, Washington DC, USA.
Shakila ThangaratinamWHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK s.thangaratinam.1@bham.ac.uk.ORCID 0000-0002-4254-460X
PregCOV-19 Living Systematic Review Consortium
University of Birmingham · GBWorld Health Organization · CHBirmingham Women's Hospital · GBSt George's, University of London · GBElizabeth Glaser Pediatric AIDS Foundation · USInstituto Ramón y Cajal de Investigación Sanitaria · ESQueen Mary University of London · GBUniversity College Cork · IEUniversity of Amsterdam · NLUniversity of Nottingham · GB

Funding

World Health Organization 001
6 · The paper itself

Abstract

objectivesTo assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.

designLiving systematic review and meta-analysis. DATA SOURCES: Major databases between 1 December 2019 and 3 August 2021. STUDY SELECTION: Cohort studies of pregnant and recently pregnant women (including after abortion or miscarriage) who sought hospital care for any reason and had a diagnosis of SARS-CoV-2 infection, and also provided data on offspring SARS-CoV-2 status and risk factors for positivity. Case series and case reports were also included to assess the timing and likelihood of mother-to-child transmission in SARS-CoV-2 positive babies. DATA EXTRACTION: Two reviewers independently extracted data and assessed study quality. A random effects model was used to synthesise data for rates, with associations reported using odds ratios and 95% confidence intervals. Narrative syntheses were performed when meta-analysis was inappropriate. The World Health Organization classification was used to categorise the timing of mother-to-child transmission (in utero, intrapartum, early postnatal).

results472 studies (206 cohort studies, 266 case series and case reports; 28 952 mothers, 18 237 babies) were included. Overall, 1.8% (95% confidence interval 1.2% to 2.5%; 140 studies) of the 14 271 babies born to mothers with SARS-CoV-2 infection tested positive for the virus with reverse transcriptase polymerase chain reaction (RT-PCR). Of the 592 SARS-CoV-2 positive babies with data on the timing of exposure and type and timing of tests, 14 had confirmed mother-to-child transmission: seven in utero (448 assessed), two intrapartum (18 assessed), and five during the early postnatal period (70 assessed). Of the 800 SARS-CoV-2 positive babies with outcome data, 20 were stillbirths, 23 were neonatal deaths, and eight were early pregnancy losses; 749 babies were alive at the end of follow-up. Severe maternal covid-19 (odds ratio 2.4, 95% confidence interval 1.3 to 4.4), maternal death (14.1, 4.1 to 48.0), maternal admission to an intensive care unit (3.5, 1.7 to 6.9), and maternal postnatal infection (5.0, 1.2 to 20.1) were associated with SARS-CoV-2 positivity in offspring. Positivity rates using RT-PCR varied between regions, ranging from 0.1% (95% confidence interval 0.0% to 0.3%) in studies from North America to 5.7% (3.2% to 8.7%) in studies from Latin America and the Caribbean.

conclusionSARS-CoV-2 positivity rates were found to be low in babies born to mothers with SARS-CoV-2 infection. Evidence suggests confirmed vertical transmission of SARS-CoV-2, although this is likely to be rare. Severity of maternal covid-19 appears to be associated with SARS-CoV-2 positivity in offspring. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020178076. READERS' NOTE: This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication.

Indexed as

Infectious Disease Transmission, VerticalPregnancy Complications, InfectiousSARS-CoV-2COVID-19COVID-19 Nucleic Acid TestingCOVID-19 TestingFemaleHumansInfant, NewbornPregnancyPregnancy Outcome

Identifiers

PMID35296519
PMCPMC8924705
OpenAlexW4221063625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.